1. Home
  2. |Insights
  3. |Pitiful Price Evaluation Unfairly Caters To Certain Bidders

Pitiful Price Evaluation Unfairly Caters To Certain Bidders

Client Alert | less than 1 min read | 01.03.06

In R&G Food Service, Inc., d/b/a Port-a-Pit Catering (Sept. 15, 2005 http://www.gao.gov/ decisions/bidpro/2964354.pdf), GAO sustained the protester's challenge to the agency's determination that its prices were not fair and reasonable. The GAO's found that, by improperly limiting its price evaluation to an examination of unit prices without also considering the estimated quantities of each item, the agency therefore failed to consider the likely actual cost to the government from the competing proposals.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights